Plasma interleukin‐22 levels are associated with prediabetes and type 2 diabetes in the Han Chinese population

Abstract

Aims/IntroductionThe objective of the present study was to investigate the relationship between plasma interleukin‐22 (IL‐22) levels and prediabetes or type 2 diabetes, and search the relevance between plasma concentrations of IL‐22 and selected diabetes risk factors in Chinese people.Materials and MethodsThe Han Chinese origin men and women participants were recruited in our study during a conventional medical checkup. Fasting plasma IL‐22 levels were detected by enzyme‐linked immunosorbent assay, and their relevance with selected diabetes risk factors was explored. Multiple logistic regression analysis was carried out to assess the odds ratio of impaired fasting glucose (IFG) and type 2 diabetes according to plasma IL‐22 level.ResultsCompared with normal glucose participants (250 pg/mL [interquartile range 154–901]), the plasma IL‐22 levels in IFG participants (185 pg/mL [interquartile range 145–414]) and type 2 diabetes participants (162 pg/mL [interquartile range 128–266]) were significantly lower (P < 0.05, P < 0.001, respectively). Correlation analysis showed that plasma concentrations of IL‐22 were negatively associated with some diabetes risk factors, including body mass index, glucose, systolic blood pressure, diastolic blood pressure and triglyceride. Furthermore, the plasma concentrations of IL‐22 showed a highly significant association with IFG and type 2 diabetes.ConclusionsIn Chinese subjects, the plasma concentration of IL‐22 is profoundly associated with susceptibility to IFG and type 2 diabetes, and decreased plasma IL‐22 level is a potential trigger of IFG and type 2 diabetes.

Longitudinal Analysis of Serum Cytokine Levels and Gut Microbial Abundance Links IL-17/IL-22 With Clostridia and Insulin Sensitivity in Humans

“…We next considered the possibility that discrete IL-17/IL-22 cytokine profiles may reflect different stages of metabolic disease progression. Previous studies in mice demonstrated that HFD-induced onset of metabolic disease is associated with loss of CD4 + IL-17–producing cells in the SILP ( 14 ), while studies in humans have shown a negative correlation between serum IL-22 levels and physiological indicators of T2D ( 21 ). We therefore hypothesized that individuals with an LA profile would show a more severe metabolic phenotype than individuals with an HA profile.…”

“…In humans, low IL-22 has been associated with impaired fasting glucose and T2D ( 21 ). However, the relationship between IL-17/IL-22 production, the microbiome, and metabolic diseases remains controversial ( 22 – 24 ) and comparatively understudied.…”

Vitamin D status influences cytokine production and MALAT1 expression from the PBMCs of patients with coronary artery disease and healthy controls

“…So far, few studies have been performed on the role of IL-22 in CAD. Shen et al 15 reported that plasma concentrations of IL-22 are decreased in impaired fasting glucose (IFG) and T2DM patients, and decreased plasma concentrations of IL-22 is an independently susceptible factor for IFG and T2DM. Decreased plasma IL-22 levels increase the morbidity of diabetes.…”

Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies

“…IL‐22 is another cytokine strongly associated with T2DM and prediabetes . In Han Chinese population, serum IL‐22 levels were significantly and progressively lower in participants with impaired fasting glucose and T2DM compared with normal participants .…”

“…IL‐22 is another cytokine strongly associated with T2DM and prediabetes . In Han Chinese population, serum IL‐22 levels were significantly and progressively lower in participants with impaired fasting glucose and T2DM compared with normal participants . IL‐22 receptor‐deficient mice fed with high‐fat diet were susceptible to development of metabolic syndrome while exogenous administration of the cytokine to high‐fat‐diet‐fed obese db/db mice improved insulin sensitivity and glucose metabolism .…”